Zivo Bioscience, Inc. financial data

Symbol
ZIVO, ZIVOW on OTC
Location
Bloomfield Hills, MI
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30% % 63%
Debt-to-equity -153% % -20%
Return On Assets -801% % 64%
Operating Margin -4046% % 77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,888,595 shares 9.7%
Common Stock, Shares, Outstanding 3,832,327 shares 9.8%
Entity Public Float $15,600,000 USD -9.8%
Common Stock, Value, Issued $3,832 USD 9.8%
Weighted Average Number of Shares Outstanding, Diluted 3,817,172 shares 12%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $209,025 USD 165%
Revenue from Contract with Customer, Excluding Assessed Tax $209,025 USD 165%
Research and Development Expense $3,695,819 USD 15%
General and Administrative Expense $4,826,813 USD -54%
Operating Income (Loss) $8,456,422 USD 38%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $8,485,861 USD 38%
Earnings Per Share, Diluted -2 USD/shares 60%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $281,399 USD -36%
Operating Lease, Right-of-Use Asset $270,373 USD 1112%
Assets $559,452 USD 13%
Accounts Payable, Current $992,990 USD 26%
Accrued Liabilities, Current $1,613,940 USD 43%
Liabilities, Current $3,614,268 USD 40%
Operating Lease, Liability, Noncurrent $220,124 USD
Liabilities $3,846,055 USD 49%
Retained Earnings (Accumulated Deficit) $143,851,025 USD -6.3%
Stockholders' Equity Attributable to Parent $3,286,603 USD -58%
Liabilities and Equity $559,452 USD 13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,430,238 USD 16%
Net Cash Provided by (Used in) Financing Activities $404,985 USD -74%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 25,000,000 shares 0%
Common Stock, Shares, Issued 3,832,327 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $57,222 USD -64%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,400 USD 17%
Deferred Tax Assets, Valuation Allowance $13,732,558 USD 11%
Operating Lease, Liability $285,837 USD
Lessee, Operating Lease, Liability, to be Paid $354,871 USD
Operating Lease, Liability, Current $65,713 USD 198%
Lessee, Operating Lease, Liability, to be Paid, Year Two $97,695 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $94,676 USD 1923%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $69,034 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $60,910 USD
Preferred Stock, Shares Issued 3,490,396 shares 100%
Lessee, Operating Lease, Liability, to be Paid, Year Four $62,747 USD
Additional Paid in Capital $140,560,590 USD 5.5%
Deferred Tax Assets, Net of Valuation Allowance $13,732,734 USD 11%
Interest Expense $12,959 USD 51%